Recent data reveals that retatrutide, a innovative medication, might represent a considerable advance in body management. This therapy combines the effects of a GLP-1 agonist and a GIP analog, possibly offering a greater outcome than existing therapies . Study research have revealed promising outcomes, including considerable decreases in size and a